| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |